Search Results - Massimo Breccia

Refine Results
  1. 1

    SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs by Massimo Breccia, Giuliana Alimena

    Get full text
    Article


  2. 2

    Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia by matteo molica, elisabetta abruzzese, massimo breccia

    Get full text
    Article


  3. 3

    MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY by Francesco Lococo, Roberto Latagliata, Massimo Breccia

    Get full text
    Article


  4. 4

    Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia by Massimo Breccia, Gioia Colafigli, Luisa Quattrocchi, elisabetta abruzzese, giuliana alimena

    Get full text
    Article


  5. 5

    MDS-specific comorbidity index is useful to identify myelodysplastic patients who can have better outcome with 5-azacitidine by Massimo Breccia, Adriano Salaroli, Giuseppina Loglisci, Paola Finsinger, Alessandra Serrao, Giuliana Alimena

    Published in Haematologica (2012-02-01)
    Get full text
    Article


  6. 6

    The incidence of pleural and pericardial effusion is not higher in patients receiving dasatinib at low doses. (Reply) by Giuseppe Visani, Massimo Breccia, Enrico Montefusco, Enrica Morra, Valeria Santini, Alessandro Isidori

    Published in Haematologica (2011-04-01)
    Get full text
    Article


  7. 7

    Clinical and Psychological Factors to Consider in Achieving Treatment-Free Remission in Patients With Chronic Myeloid Leukemia by Massimo Breccia, Elisabetta Abruzzese, Mario Annunziata, Luigia Luciano, Simona Sica, Simona Sica

    Published in Frontiers in Oncology (2021-03-01)
    Get full text
    Article


  8. 8

    Evaluation of overall survival according to myelodysplastic syndrome-specific comorbidity index in a large series of myelodysplastic syndromes by Massimo Breccia, Vincenzo Federico, Giuseppina Loglisci, Adriano Salaroli, Alessandra Serrao, Giuliana Alimena

    Published in Haematologica (2011-10-01)
    Get full text
    Article


  9. 9

    The degree of anemia has an impact on survival in myelodysplastic syndrome patients classified with WPSS by Massimo Breccia, Giuseppina Loglisci, Paola Finsinger, Adriano Salaroli, Alessandra Serrao, Giuliana Alimena

    Published in Haematologica (2011-12-01)
    Get full text
    Article


  10. 10

    Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia by Massimo Breccia, Laura Cicconi, Clara Minotti, Roberto Latagliata, Laura Giannì, Francesco Lo-Coco

    Published in Haematologica (2011-09-01)
    Get full text
    Article


  11. 11

    Sustained molecular remission after low dose gemtuzumab-ozogamicin in elderly patients with advanced acute promyelocytic leukemia by Massimo Breccia, Giuseppe Cimino, Daniela Diverio, Fabiana Gentilini, Franco Mandelli, Francesco Lo Coco

    Published in Haematologica (2007-09-01)
    Get full text
    Article


  12. 12

    Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation by Massimo Breccia, Roberto Latagliata, Laura Cannella, Clara Minotti, Giovanna Meloni, Francesco Lo-Coco

    Published in Haematologica (2010-05-01)
    Get full text
    Article


  13. 13

    Red Blood Cell Distribution Width May Predict Drug-Induced Anemia and Prognosis in Patients Affected by Primary/Secondary Myelofibrosis Treated with Ruxolitinib by Alessandro Laganà, Emilia Scalzulli, Ida Carmosino, Maria L. Bisegna, Maurizio Martelli, Massimo Breccia

    Published in Oncology and Therapy (2025-01-01)
    Get full text
    Article


  14. 14

    Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives by Massimo Breccia, Francesca Palandri, Nicola Polverelli, Morena Caira, Michela Berluti, Giuseppe A. Palumbo, Valerio De Stefano

    Published in Frontiers in Oncology (2024-07-01)
    Get full text
    Article


  15. 15

    Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase by Massimo Breccia, Elisabetta Abruzzese, Alessandra Iurlo, Antonella Gozzini, Alessandro Isidori, Domenica Gangemi, Patrizia Pregno, Giuliana Alimena

    Published in Haematologica (2016-06-01)
    Get full text
    Article


  16. 16

    Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination by Chiara Masucci, Mauro Passucci, Emilia Scalzulli, Ida Carmosino, Marcello Capriata, Alessandro Costa, Claudia Ielo, Maurizio Martelli, Massimo Breccia

    Published in Frontiers in Oncology (2023-06-01)
    Get full text
    Article


  17. 17

    FLT3-ITD confers poor prognosis in patients with acute promyelocytic leukemia treated with AIDA protocols: long-term follow-up analysis by Massimo Breccia, Giuseppina Loglisci, Maria Giovanna Loglisci, Roberto Ricci, Daniela Diverio, Roberto Latagliata, Robin Foà, Francesco Lo-Coco

    Published in Haematologica (2013-12-01)
    Get full text
    Article


  18. 18

    LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE by Michelina Santopietro, Giuseppina Loglisci, Roberto Latagliata, Corrado Girmenia, Massimo Breccia, Vincenzo Federico, Luigi Petrucci, Alessandra Serrao, Adriano Salaroli, Giuliana Alimena

    Get full text
    Article


  19. 19

    LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE by Massimo Breccia, Corrado Girmenia, Roberto Latagliata, Giuseppina Loglisci, Michelina Santopietro, Vincenzo Federico, Luigi Petrucci, Alessandra Serrao, Adriano Salaroli, Giuliana Alimena

    Get full text
    Article


  20. 20

    Case Report: Infectious prophylaxis in hematological malignancies by Mauro Passucci, Chiara Masucci, Francesca Paoletti, Claudia Ielo, Alessandro Costa, Ida Carmosino, Emilia Scalzulli, Maurizio Martelli, Giuseppe Gentile, Massimo Breccia

    Published in Frontiers in Oncology (2023-05-01)
    Get full text
    Article


Search Tools: